Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

Guardado en:

Detalles Bibliográficos
Autores principales:	Mina C. Hosseinipour, Gregory P. Bisson, Sachiko Miyahara, Xin Sun, Agnes Moses, Cynthia Riviere, Fredrick K Kirui, Sharlaa Badal‐Faesen, David Lagat, Mulinda Nyirenda, Kogieleum Naidoo, James Hakim, Peter Mugyenyi, Germán Henostroza, Paul Leger, Javier R. Lama, Lerato Mohapi, Jorge Alave, Vidya Mave, Valdiléa G. Veloso, Sandy Pillay, Nagalingeswaran Kumarasamy, Jing Bao, Evelyn Hogg, Lynne Jones, Andrew Zolopa, Johnstone Kumwenda, Amita Gupta
Formato:	Artículo
Lenguaje:	inglés
Publicado:	2016
Materias:	Medicine Tuberculosis Isoniazid Internal medicine Clinical endpoint Population Randomized controlled trial Pediatrics Environmental health Pathology Adult Ambulatory Care Facilities Antitubercular Agents therapeutic use Female Humans Isoniazid therapeutic use Male Tuberculosis immunology Tuberculosis prevention & control HIV Infections drug therapy HIV Infections immunology Treatment Outcome AIDS-Related Opportunistic Infections immunology AIDS-Related Opportunistic Infections prevention & control CD4 Lymphocyte Count Anti-HIV Agents therapeutic use Kaplan-Meier Estimate Health Sciences Medicine Infectious Diseases HIV/AIDS drug development and treatment Health Sciences Medicine Infectious Diseases Tuberculosis Research and Epidemiology Health Sciences Medicine Infectious Diseases HIV/AIDS Research and Interventions
Acceso en línea:	Ver en el sistema de origen Ver en el sistema de origen Enlace permanente (DOI o Handle)
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Descripción
Descripción no disponible.